269 results on '"Pulendran, Bali"'
Search Results
2. Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
3. Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
4. Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
5. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth
6. Systems Biological Approaches for Mucosal Vaccine Development
7. List of Contributors
8. Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
9. Integrated Organ Immunity: Antigen-specific CD4-T cell-derived IFN-γ induced by BCG imprints prolonged lung innate resistance against respiratory viruses
10. Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Improve Vaccine Immunomodulation
11. Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans
12. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
13. Circular RNA vaccine induces potent T cell responses
14. Robust T cell responses to the Pfizer/BioNTech vaccine compared to infection and evidence of attenuated CD8+ T cell responses due to COVID-19
15. Disease Tolerance Acquired Through Repeated Plasmodium Infection Involves Epigenetic Reprogramming of Innate Immune Cells
16. A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
17. Progress in vaccine development for infectious diseases—a Keystone Symposia report
18. Durability of immune responses to the booster mRNA vaccination against COVID-19
19. Robust T cell responses to Pfizer/BioNTech vaccine compared to infection and evidence of attenuated peripheral CD8+ T cell responses due to COVID-19
20. Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life
21. A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2
22. Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2
23. Disease Tolerance of Malaria Involves Epigenetic Reprogramming of Innate Immune Cells
24. Robust T Cell Responses to the Pfizer/BioNTech Vaccine Compared to Infection and Evidence of Attenuated CD8 T Cell Responses Due to COVID-19
25. Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2
26. SREBP signaling is essential for effective B cell responses
27. A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
28. Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability
29. Designing epitope-focused vaccinesviaantigen reorientation
30. Durability of immune responses to the booster mRNA vaccination against COVID-19
31. The persistence of memory: defining, engineering, and measuring vaccine durability
32. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
33. Inhibition of CHK2 dependent DNA damage response suppresses Zika virus infection through a STING dependent mechanism
34. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
35. Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
36. Author response: Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
37. Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
38. Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants
39. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
40. Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
41. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
42. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
43. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
44. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
45. Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
46. Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
47. The Single Cell Transcriptomic and Epigenomic Map of the Innate Immune Response to Vaccination in Lymph Nodes
48. Natural resistance against infections: focus on COVID-19
49. A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
50. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.